IL6 and familial pancreatic carcinoma: On this basis, we further investigated the changes in miR-365/BTG2/IL-6 caused by BA and discovered that both BA and miR-365 inhibitors could increase the expression of BTG2 and reduce the level of IL-6 in pancreatic cancer cells, and the combination of BA and miR-365 inhibitors could result in better outcome.